Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Nix

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Open Forum Infectious Diseases|August 4, 2023
Trends of Azole Antifungal Prescription in the United States: Medicare Part D Provider Utilization and Payment Data AnalysisMohanad M Al-Obaidi, Luis Ostrosky-Zeichner, David E Nix
International Journal of Pharmaceutical Compounding|March 24, 2017
Stability of Ampicillin in Normal Saline and Buffered Normal SalineMoureddine Maher, Kara J Jensen, David Lee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 30, 2020
Fixed Dosing of Amphotericin B in Morbidly Obese IndividualsDavid E Nix, Justin F Hayes, Mohanad Al Obaidi, et al.
Open Forum Infectious Diseases|February 12, 2021
Clinical and Economic Burden of Valley Fever in Arizona: An Incidence-Based Cost-of-Illness AnalysisAmy J Grizzle, Leslie Wilson, David E Nix, et al.
Antimicrobial Agents and Chemotherapy|April 8, 2009
Pharmacokinetics of nikkomycin Z after single rising oral dosesDavid E Nix, Robert R Swezey, Richard Hector, et al.
Antimicrobial Agents and Chemotherapy|June 6, 2025
Pharmacokinetics of nikkomycin Z following multiple doses in healthy subjectsDavid E Nix, Susan E Hoover, Nathan J Hanan, et al.
Expert Opinion on Pharmacotherapy|March 25, 2026
Past, present, and emerging antifungals against <i>Fusarium and</i> other rare non-<i>aspergillus</i> hyalohyphomycetes: a narrative reviewMohanad M Al-Obaidi, Saman Nematollahi, Justin Hayes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 5, 2021
Remarks on the Universal Lifelong Coccidioidomycosis Prophylaxis in Lung Transplant RecipientsMohanad M Al-Obaidi, Saman Nematollahi, David E Nix, et al.
The Annals of Pharmacotherapy|August 9, 2012
Poor absorption of high-dose posaconazole in pediatric bone marrow transplant patientsKathryn R Matthias, David E Nix, Charles A Peloquin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2025
Responding to Additional Considerations Regarding the Risk of Acute Kidney Injury With Cefepime Versus Piperacillin-Tazobactam in Patients With Septic ShockAsad E Patanwala, David E Nix, Thomas E Hills, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Open Forum Infectious Diseases|August 4, 2023
Trends of Azole Antifungal Prescription in the United States: Medicare Part D Provider Utilization and Payment Data AnalysisMohanad M Al-Obaidi, Luis Ostrosky-Zeichner, David E Nix
International Journal of Pharmaceutical Compounding|March 24, 2017
Stability of Ampicillin in Normal Saline and Buffered Normal SalineMoureddine Maher, Kara J Jensen, David Lee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 30, 2020
Fixed Dosing of Amphotericin B in Morbidly Obese IndividualsDavid E Nix, Justin F Hayes, Mohanad Al Obaidi, et al.
Open Forum Infectious Diseases|February 12, 2021
Clinical and Economic Burden of Valley Fever in Arizona: An Incidence-Based Cost-of-Illness AnalysisAmy J Grizzle, Leslie Wilson, David E Nix, et al.
Antimicrobial Agents and Chemotherapy|April 8, 2009
Pharmacokinetics of nikkomycin Z after single rising oral dosesDavid E Nix, Robert R Swezey, Richard Hector, et al.
Antimicrobial Agents and Chemotherapy|June 6, 2025
Pharmacokinetics of nikkomycin Z following multiple doses in healthy subjectsDavid E Nix, Susan E Hoover, Nathan J Hanan, et al.
Expert Opinion on Pharmacotherapy|March 25, 2026
Past, present, and emerging antifungals against <i>Fusarium and</i> other rare non-<i>aspergillus</i> hyalohyphomycetes: a narrative reviewMohanad M Al-Obaidi, Saman Nematollahi, Justin Hayes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 5, 2021
Remarks on the Universal Lifelong Coccidioidomycosis Prophylaxis in Lung Transplant RecipientsMohanad M Al-Obaidi, Saman Nematollahi, David E Nix, et al.
The Annals of Pharmacotherapy|August 9, 2012
Poor absorption of high-dose posaconazole in pediatric bone marrow transplant patientsKathryn R Matthias, David E Nix, Charles A Peloquin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2025
Responding to Additional Considerations Regarding the Risk of Acute Kidney Injury With Cefepime Versus Piperacillin-Tazobactam in Patients With Septic ShockAsad E Patanwala, David E Nix, Thomas E Hills, et al.
Pageof 7